These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33139459)

  • 1. Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent Model.
    Couto N; Newton JRA; Russo C; Karunakaran E; Achour B; Al-Majdoub ZM; Sidaway J; Rostami-Hodjegan A; Clench MR; Barber J
    Drug Metab Dispos; 2021 Jan; 49(1):39-52. PubMed ID: 33139459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
    Oesch F; Fabian E; Guth K; Landsiedel R
    Arch Toxicol; 2014 Dec; 88(12):2135-90. PubMed ID: 25370008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes.
    Götz C; Pfeiffer R; Tigges J; Ruwiedel K; Hübenthal U; Merk HF; Krutmann J; Edwards RJ; Abel J; Pease C; Goebel C; Hewitt N; Fritsche E
    Exp Dermatol; 2012 May; 21(5):364-9. PubMed ID: 22509834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.
    Hewitt NJ; Edwards RJ; Fritsche E; Goebel C; Aeby P; Scheel J; Reisinger K; Ouédraogo G; Duche D; Eilstein J; Latil A; Kenny J; Moore C; Kuehnl J; Barroso J; Fautz R; Pfuhler S
    Toxicol Sci; 2013 Jun; 133(2):209-17. PubMed ID: 23539547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.
    Eilstein J; Léreaux G; Budimir N; Hussler G; Wilkinson S; Duché D
    Arch Toxicol; 2014 Sep; 88(9):1681-1694. PubMed ID: 24658324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling.
    van Eijl S; Zhu Z; Cupitt J; Gierula M; Götz C; Fritsche E; Edwards RJ
    PLoS One; 2012; 7(7):e41721. PubMed ID: 22848577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro.
    Fabian E; Vogel D; Blatz V; Ramirez T; Kolle S; Eltze T; van Ravenzwaay B; Oesch F; Landsiedel R
    Arch Toxicol; 2013 Sep; 87(9):1683-96. PubMed ID: 23958860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin.
    Hu T; Khambatta ZS; Hayden PJ; Bolmarcich J; Binder RL; Robinson MK; Carr GJ; Tiesman JP; Jarrold BB; Osborne R; Reichling TD; Nemeth ST; Aardema MJ
    Toxicol In Vitro; 2010 Aug; 24(5):1450-63. PubMed ID: 20350595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.
    Bacqueville D; Jacques C; Duprat L; Jamin EL; Guiraud B; Perdu E; Bessou-Touya S; Zalko D; Duplan H
    Toxicol Appl Pharmacol; 2017 Aug; 329():190-201. PubMed ID: 28601433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and redox barriers in the skin exposed to drugs and xenobiotics.
    Korkina L
    Expert Opin Drug Metab Toxicol; 2016; 12(4):377-88. PubMed ID: 26854731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
    Wegler C; Gaugaz FZ; Andersson TB; Wiśniewski JR; Busch D; Gröer C; Oswald S; Norén A; Weiss F; Hammer HS; Joos TO; Poetz O; Achour B; Rostami-Hodjegan A; van de Steeg E; Wortelboer HM; Artursson P
    Mol Pharm; 2017 Sep; 14(9):3142-3151. PubMed ID: 28767254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
    Oesch F; Fabian E; Landsiedel R
    Arch Toxicol; 2018 Aug; 92(8):2411-2456. PubMed ID: 29916051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics.
    Couto N; Al-Majdoub ZM; Achour B; Wright PC; Rostami-Hodjegan A; Barber J
    Mol Pharm; 2019 Feb; 16(2):632-647. PubMed ID: 30608694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I).
    Götz C; Pfeiffer R; Tigges J; Blatz V; Jäckh C; Freytag EM; Fabian E; Landsiedel R; Merk HF; Krutmann J; Edwards RJ; Pease C; Goebel C; Hewitt N; Fritsche E
    Exp Dermatol; 2012 May; 21(5):358-63. PubMed ID: 22509833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and animal hepatocytes in vitro with extrapolation in vivo.
    O'Brien PJ; Chan K; Silber PM
    Chem Biol Interact; 2004 Nov; 150(1):97-114. PubMed ID: 15522264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes.
    El-Khateeb E; Al-Majdoub ZM; Rostami-Hodjegan A; Barber J; Achour B
    Drug Metab Dispos; 2021 Aug; 49(8):610-618. PubMed ID: 34045218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysis.
    Al Feteisi H; Achour B; Barber J; Rostami-Hodjegan A
    AAPS J; 2015 Mar; 17(2):438-46. PubMed ID: 25663651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems.
    Nakata K; Tanaka Y; Nakano T; Adachi T; Tanaka H; Kaminuma T; Ishikawa T
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):437-57. PubMed ID: 17220560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.